A licensed pharmacist in Saudi Arabia dispenses a medicine that appears on the qualifying list jointly maintained by the Ministry of Health and the Saudi Food and Drug Authority (SFDA), and separately sells a general wellness supplement that does not appear on that list. Under the VAT Implementing Regulations, how are these two supplies treated for VAT purposes?
- The listed qualifying medicine is zero-rated, while the wellness supplement not on the list is subject to VAT at the standard rate
- Both supplies are zero-rated, because any product dispensed by a licensed pharmacist automatically qualifies for zero-rating regardless of whether it appears on the MOH/SFDA list
- Both supplies are fully exempt from VAT, because healthcare-related products as a category are excluded from the scope of VAT entirely rather than zero-rated
- The listed qualifying medicine is subject to VAT at the standard rate precisely because it is officially recognized as medicine, while the unlisted wellness supplement is zero-rated as a general consumer good
Why A? And why not the others?
Correct answer: A. The listed qualifying medicine is zero-rated, while the wellness supplement not on the list is subject to VAT at the standard rate
Zero-rating under the VAT Implementing Regulations turns on whether a specific medicine or medical item actually appears on the qualifying list maintained jointly by the Ministry of Health and the SFDA, so the listed medicine is zero-rated while the unlisted wellness supplement defaults to the standard VAT rate, regardless of who dispenses either product. The option zero-rating both supplies is wrong because zero-rating is not a blanket benefit attaching to anything sold by a pharmacist; it depends specifically on the product's own listing status, which the supplement lacks. The option treating both supplies as fully exempt is wrong because it conflates two legally distinct VAT treatments: an exempt supply sits outside the input-VAT-recovery mechanism entirely, while a zero-rated supply is still taxable, just at 0%, and healthcare products in general are not blanket-exempt in Saudi Arabia. The option reversing the treatment, taxing the listed medicine at the standard rate and zero-rating the supplement, is wrong because it inverts the entire basis for zero-rating: appearing on the official qualifying list is exactly what triggers the zero rate, not what disqualifies a product from it.
Source: Saudi VAT Implementing Regulations, Article 35 (zero-rating); Ministry of Health/SFDA qualifying medicines and medical equipment list